Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2022

16.02.2022 | Review

Endoscopic Management of Pancreatobiliary Malignancies

verfasst von: Dong Wook Lee, Eun Young Kim

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Pancreatobiliary malignancies have poor prognosis, and many patients are inoperable at the time of diagnosis. When surgical resection is impossible, systemic chemotherapy or radiotherapy is traditionally conducted with trial of immunotherapy or gene therapy lately. With the rapid development of endoscopic instruments and accessories in recent years, not only endoscopic early detection, characterization, and staging but also endoscopic palliative management of the pancreatobiliary malignancies is expanding the horizons. Endoscopic management is often preferred due to similar efficacy to surgical management with less morbidity. Here, we review the methodology and treatment outcome of various endoscopic management strategies in pancreatobiliary malignancies including endoscopic complication management, local palliative therapy, endoscopy-assisted therapy, and pain control utilizing endoscopic retrograde cholangiopancreatography or endoscopic ultrasound.
Literatur
1.
Zurück zum Zitat de Moura DTH, Ryou M, de Moura EGH, Ribeiro IB, Bernardo WM, Thompson CC. Endoscopic ultrasound-guided fine needle aspiration and endoscopic retrograde cholangiopancreatography-based tissue sampling in suspected malignant biliary strictures: a meta-analysis of same-session procedures. Clin Endosc. 2020;53:417–428.PubMedCrossRef de Moura DTH, Ryou M, de Moura EGH, Ribeiro IB, Bernardo WM, Thompson CC. Endoscopic ultrasound-guided fine needle aspiration and endoscopic retrograde cholangiopancreatography-based tissue sampling in suspected malignant biliary strictures: a meta-analysis of same-session procedures. Clin Endosc. 2020;53:417–428.PubMedCrossRef
2.
Zurück zum Zitat Nakai Y, Takahara N, Mizuno S, Kogure H, Koike K. Current status of endoscopic ultrasound techniques for pancreatic neoplasms. Clin Endosc. 2019;52:527–532.PubMedPubMedCentralCrossRef Nakai Y, Takahara N, Mizuno S, Kogure H, Koike K. Current status of endoscopic ultrasound techniques for pancreatic neoplasms. Clin Endosc. 2019;52:527–532.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Suker M, Beumer BR, Sadot E et al. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016;17:801–810.PubMedPubMedCentralCrossRef Suker M, Beumer BR, Sadot E et al. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016;17:801–810.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Almadi MA, Barkun A, Martel M. Plastic vs. self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses. Am J Gastroenterol. 2017;112:260–273. Almadi MA, Barkun A, Martel M. Plastic vs. self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses. Am J Gastroenterol. 2017;112:260–273.
6.
Zurück zum Zitat Walter D, van Boeckel PG, Groenen MJ et al. Cost efficacy of metal stents for palliation of extrahepatic bile duct obstruction in a randomized controlled trial. Gastroenterology. 2015;149:130–138.PubMedCrossRef Walter D, van Boeckel PG, Groenen MJ et al. Cost efficacy of metal stents for palliation of extrahepatic bile duct obstruction in a randomized controlled trial. Gastroenterology. 2015;149:130–138.PubMedCrossRef
7.
Zurück zum Zitat Kitano M, Yamashita Y, Tanaka K et al. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial. Am J Gastroenterol. 2013;108:1713–1722.PubMedCrossRef Kitano M, Yamashita Y, Tanaka K et al. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial. Am J Gastroenterol. 2013;108:1713–1722.PubMedCrossRef
8.
Zurück zum Zitat Kullman E, Frozanpor F, Söderlund C et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:915–923.PubMedCrossRef Kullman E, Frozanpor F, Söderlund C et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:915–923.PubMedCrossRef
9.
Zurück zum Zitat Ung KA, Stotzer PO, Nilsson A, Gustavsson ML, Johnsson E. Covered and uncovered self-expandable metallic Hanarostents are equally efficacious in the drainage of extrahepatic malignant strictures. Results of a double-blind randomized study. Scand J Gastroenterol. 2013;48:459–465. Ung KA, Stotzer PO, Nilsson A, Gustavsson ML, Johnsson E. Covered and uncovered self-expandable metallic Hanarostents are equally efficacious in the drainage of extrahepatic malignant strictures. Results of a double-blind randomized study. Scand J Gastroenterol. 2013;48:459–465.
10.
Zurück zum Zitat Nakai Y, Isayama H, Kawakubo K et al. Metallic stent with high axial force as a risk factor for cholecystitis in distal malignant biliary obstruction. J Gastroenterol Hepatol. 2014;29:1557–1562.PubMedCrossRef Nakai Y, Isayama H, Kawakubo K et al. Metallic stent with high axial force as a risk factor for cholecystitis in distal malignant biliary obstruction. J Gastroenterol Hepatol. 2014;29:1557–1562.PubMedCrossRef
11.
Zurück zum Zitat Watanabe M, Okuwaki K, Woo J et al. Cholecystitis after placement of covered self-expandable metallic stents in patients with distal malignant biliary obstructions. Clin Endosc. 2021;54:589–595.PubMedCrossRef Watanabe M, Okuwaki K, Woo J et al. Cholecystitis after placement of covered self-expandable metallic stents in patients with distal malignant biliary obstructions. Clin Endosc. 2021;54:589–595.PubMedCrossRef
12.
Zurück zum Zitat Telford JJ, Carr-Locke DL, Baron TH et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72:907–914.PubMedCrossRef Telford JJ, Carr-Locke DL, Baron TH et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72:907–914.PubMedCrossRef
13.
Zurück zum Zitat Yang MJ, Kim JH, Yoo BM et al. Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: a randomized controlled trial. Scand J Gastroenterol. 2015;50:1490–1499.PubMedCrossRef Yang MJ, Kim JH, Yoo BM et al. Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: a randomized controlled trial. Scand J Gastroenterol. 2015;50:1490–1499.PubMedCrossRef
14.
Zurück zum Zitat Pfau PR, Pleskow DK, Banerjee S et al. Pancreatic and biliary stents. Gastrointest Endosc. 2013;77:319–327.PubMedCrossRef Pfau PR, Pleskow DK, Banerjee S et al. Pancreatic and biliary stents. Gastrointest Endosc. 2013;77:319–327.PubMedCrossRef
15.
Zurück zum Zitat Inoue T, Okumura F, Naitoh I et al. Feasibility of the placement of a novel 6-mm diameter threaded fully covered self-expandable metal stent for malignant hilar biliary obstructions (with videos). Gastrointest Endosc. 2016;84:352–357.PubMedCrossRef Inoue T, Okumura F, Naitoh I et al. Feasibility of the placement of a novel 6-mm diameter threaded fully covered self-expandable metal stent for malignant hilar biliary obstructions (with videos). Gastrointest Endosc. 2016;84:352–357.PubMedCrossRef
16.
Zurück zum Zitat Lee TH, Kim TH, Moon JH et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video). Gastrointest Endosc. 2017;86:817–827.PubMedCrossRef Lee TH, Kim TH, Moon JH et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video). Gastrointest Endosc. 2017;86:817–827.PubMedCrossRef
17.
Zurück zum Zitat Aghaie Meybodi M, Shakoor D, Nanavati J et al. Unilateral versus bilateral endoscopic stenting in patients with unresectable malignant hilar obstruction: a systematic review and meta-analysis. Endosc Int Open. 2020;8:E281–E290.PubMedPubMedCentralCrossRef Aghaie Meybodi M, Shakoor D, Nanavati J et al. Unilateral versus bilateral endoscopic stenting in patients with unresectable malignant hilar obstruction: a systematic review and meta-analysis. Endosc Int Open. 2020;8:E281–E290.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Naitoh I, Hayashi K, Nakazawa T et al. Side-by-side versus stent-in-stent deployment in bilateral endoscopic metal stenting for malignant hilar biliary obstruction. Dig Dis Sci. 2012;57:3279–3285.PubMedCrossRef Naitoh I, Hayashi K, Nakazawa T et al. Side-by-side versus stent-in-stent deployment in bilateral endoscopic metal stenting for malignant hilar biliary obstruction. Dig Dis Sci. 2012;57:3279–3285.PubMedCrossRef
19.
Zurück zum Zitat Kim KM, Lee KH, Chung YH et al. A comparison of bilateral stenting methods for malignant hilar biliary obstruction. Hepatogastroenterology. 2012;59:341–346.PubMedCrossRef Kim KM, Lee KH, Chung YH et al. A comparison of bilateral stenting methods for malignant hilar biliary obstruction. Hepatogastroenterology. 2012;59:341–346.PubMedCrossRef
20.
Zurück zum Zitat Song TJ, Lee SS, Yun SC et al. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study. Gastrointest Endosc. 2011;73:727–733.PubMedCrossRef Song TJ, Lee SS, Yun SC et al. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study. Gastrointest Endosc. 2011;73:727–733.PubMedCrossRef
21.
Zurück zum Zitat Jang SI, Lee KT, Choi JS et al. Efficacy of a paclitaxel-eluting biliary metal stent with sodium caprate in malignant biliary obstruction: a prospective randomized comparative study. Endoscopy. 2019;51:843–851.PubMedCrossRef Jang SI, Lee KT, Choi JS et al. Efficacy of a paclitaxel-eluting biliary metal stent with sodium caprate in malignant biliary obstruction: a prospective randomized comparative study. Endoscopy. 2019;51:843–851.PubMedCrossRef
22.
Zurück zum Zitat Tendler DA. Malignant gastric outlet obstruction: bridging another divide. Am J Gastroenterol. 2002;97:4–6.PubMedCrossRef Tendler DA. Malignant gastric outlet obstruction: bridging another divide. Am J Gastroenterol. 2002;97:4–6.PubMedCrossRef
23.
Zurück zum Zitat Hong SK, Jang JY, Kang MJ, Han IW, Kim SW. Comparison of clinical outcome and cost-effectiveness after various preoperative BDmethods in periampullary cancer with obstructive jaundice. J Korean Med Sci. 2012;27:356–362.PubMedPubMedCentralCrossRef Hong SK, Jang JY, Kang MJ, Han IW, Kim SW. Comparison of clinical outcome and cost-effectiveness after various preoperative BDmethods in periampullary cancer with obstructive jaundice. J Korean Med Sci. 2012;27:356–362.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Sharaiha RZ, Khan MA, Kamal F et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017;85:904–914.PubMedCrossRef Sharaiha RZ, Khan MA, Kamal F et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017;85:904–914.PubMedCrossRef
25.
Zurück zum Zitat Mukai S, Itoi T. EUS-guided antegrade procedures. Endosc. Ultrasound. 2019;8:S7–S13. Mukai S, Itoi T. EUS-guided antegrade procedures. Endosc. Ultrasound. 2019;8:S7–S13.
26.
Zurück zum Zitat Park JK, Woo YS, Noh DH et al. Efficacy of EUS-guided and ERCP-guided biliary drainage for malignant biliary obstruction: prospective randomized controlled study. Gastrointest Endosc. 2018;88:277–282.PubMedCrossRef Park JK, Woo YS, Noh DH et al. Efficacy of EUS-guided and ERCP-guided biliary drainage for malignant biliary obstruction: prospective randomized controlled study. Gastrointest Endosc. 2018;88:277–282.PubMedCrossRef
27.
Zurück zum Zitat Paik WH, Lee TH, Park DH et al. EUS-guided biliary drainage versus ERCP for the primary palliation of malignant biliary obstruction: a multicenter randomized clinical trial. Am J Gastroenterol. 2018;113:987–997.PubMedCrossRef Paik WH, Lee TH, Park DH et al. EUS-guided biliary drainage versus ERCP for the primary palliation of malignant biliary obstruction: a multicenter randomized clinical trial. Am J Gastroenterol. 2018;113:987–997.PubMedCrossRef
28.
Zurück zum Zitat Miller CS, Barkun AN, Martel M, Chen YI. Endoscopic ultrasound-guided biliary drainage for distal malignant obstruction: a systematic review and meta-analysis of randomized trials. Endosc Int Open. 2019;7:E1563–E1573.PubMedPubMedCentralCrossRef Miller CS, Barkun AN, Martel M, Chen YI. Endoscopic ultrasound-guided biliary drainage for distal malignant obstruction: a systematic review and meta-analysis of randomized trials. Endosc Int Open. 2019;7:E1563–E1573.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Fingar VH, Taber SW, Haydon PS, Harrison LT, Kempf SJ, Wieman TJ. Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville. In Vivo. 2000;14:93–100.PubMed Fingar VH, Taber SW, Haydon PS, Harrison LT, Kempf SJ, Wieman TJ. Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville. In Vivo. 2000;14:93–100.PubMed
31.
Zurück zum Zitat Dougherty TJ. An update on photodynamic therapy applications. J Clin Laser Med Surg. 2002;20:3–7.PubMedCrossRef Dougherty TJ. An update on photodynamic therapy applications. J Clin Laser Med Surg. 2002;20:3–7.PubMedCrossRef
32.
Zurück zum Zitat Peng Q, Moan J, Nesland JM. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol. 1996;20:109–129.PubMedCrossRef Peng Q, Moan J, Nesland JM. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol. 1996;20:109–129.PubMedCrossRef
33.
Zurück zum Zitat Ortner ME, Caca K, Berr F et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003;125:1355–1363.PubMedCrossRef Ortner ME, Caca K, Berr F et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003;125:1355–1363.PubMedCrossRef
34.
Zurück zum Zitat Gao F, Bai Y, Ma SR, Liu F, Li ZS. Systematic review: photodynamic therapy for unresectable cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:125–131.PubMedCrossRef Gao F, Bai Y, Ma SR, Liu F, Li ZS. Systematic review: photodynamic therapy for unresectable cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:125–131.PubMedCrossRef
35.
Zurück zum Zitat Leggett CL, Gorospe EC, Murad MH, Montori VM, Baron TH, Wang KK. Photodynamic therapy for unresectable cholangiocarcinoma: a comparative effectiveness systematic review and meta-analyses. Photodiagnosis Photodyn Ther. 2012;9:189–195.PubMedCrossRef Leggett CL, Gorospe EC, Murad MH, Montori VM, Baron TH, Wang KK. Photodynamic therapy for unresectable cholangiocarcinoma: a comparative effectiveness systematic review and meta-analyses. Photodiagnosis Photodyn Ther. 2012;9:189–195.PubMedCrossRef
36.
Zurück zum Zitat Park DH, Lee SS, Park SE et al. Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma. Eur J Cancer. 2014;50:1259–1268.PubMedCrossRef Park DH, Lee SS, Park SE et al. Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma. Eur J Cancer. 2014;50:1259–1268.PubMedCrossRef
37.
Zurück zum Zitat Lu Y, Liu L, Wu JC, Bie LK, Gong B. Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: a meta-analysis. Clin Res Hepatol Gastroenterol. 2015;39:718–724.PubMedCrossRef Lu Y, Liu L, Wu JC, Bie LK, Gong B. Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: a meta-analysis. Clin Res Hepatol Gastroenterol. 2015;39:718–724.PubMedCrossRef
38.
Zurück zum Zitat Strand DS, Cosgrove ND, Patrie JT et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma. Gastrointest Endosc. 2014;80:794–804.PubMedCrossRef Strand DS, Cosgrove ND, Patrie JT et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma. Gastrointest Endosc. 2014;80:794–804.PubMedCrossRef
39.
Zurück zum Zitat Cheon YK, Lee TY, Lee SM, Yoon JY, Shim CS. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma. HPB (Oxford). 2012;14:185–193.PubMedPubMedCentralCrossRef Cheon YK, Lee TY, Lee SM, Yoon JY, Shim CS. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma. HPB (Oxford). 2012;14:185–193.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Quyn AJ, Ziyaie D, Polignano FM, Tait IS. Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford). 2009;11:570–577.PubMedPubMedCentralCrossRef Quyn AJ, Ziyaie D, Polignano FM, Tait IS. Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford). 2009;11:570–577.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Kahaleh M, Mishra R, Shami VM et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol. 2008;6:290–297.PubMedCrossRef Kahaleh M, Mishra R, Shami VM et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol. 2008;6:290–297.PubMedCrossRef
42.
Zurück zum Zitat Witzigmann H, Berr F, Ringel U et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244:230–239.PubMedPubMedCentralCrossRef Witzigmann H, Berr F, Ringel U et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244:230–239.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol. 2005;100:2426–2430.PubMedCrossRef Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol. 2005;100:2426–2430.PubMedCrossRef
44.
Zurück zum Zitat Dumoulin FL, Gerhardt T, Fuchs S et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2003;57:860–867.PubMedCrossRef Dumoulin FL, Gerhardt T, Fuchs S et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2003;57:860–867.PubMedCrossRef
45.
Zurück zum Zitat Shafirstein G, Bellnier D, Oakley E et al. Interstitial photodynamic therapy-a focused review. Cancers (Basel). 2017;9:12.PubMedCentralCrossRef Shafirstein G, Bellnier D, Oakley E et al. Interstitial photodynamic therapy-a focused review. Cancers (Basel). 2017;9:12.PubMedCentralCrossRef
46.
Zurück zum Zitat Choi JH, Oh D, Lee JH et al. Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheter. Endoscopy. 2015;47:1035–1038.PubMedCrossRef Choi JH, Oh D, Lee JH et al. Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheter. Endoscopy. 2015;47:1035–1038.PubMedCrossRef
47.
Zurück zum Zitat DeWitt JM, Sandrasegaran K, O’Neil B et al. Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. Gastrointest Endosc. 2019;89:390–398.PubMedCrossRef DeWitt JM, Sandrasegaran K, O’Neil B et al. Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. Gastrointest Endosc. 2019;89:390–398.PubMedCrossRef
48.
Zurück zum Zitat Mirza AN, Fornage BD, Sneige N et al. Radiofrequency ablation of solid tumors. Cancer J. 2001;7:95–102.PubMed Mirza AN, Fornage BD, Sneige N et al. Radiofrequency ablation of solid tumors. Cancer J. 2001;7:95–102.PubMed
49.
Zurück zum Zitat Cho JH, Jeon TJ, Park JY et al. Comparison of outcomes among secondary covered metallic, uncovered metallic, and plastic biliary stents in treating occluded primary metallic stents in malignant distal biliary obstruction. Surg Endosc. 2011;25:475–482.PubMedCrossRef Cho JH, Jeon TJ, Park JY et al. Comparison of outcomes among secondary covered metallic, uncovered metallic, and plastic biliary stents in treating occluded primary metallic stents in malignant distal biliary obstruction. Surg Endosc. 2011;25:475–482.PubMedCrossRef
50.
Zurück zum Zitat Sofi AA, Khan MA, Das A et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2018;87:944-951.e941.PubMedCrossRef Sofi AA, Khan MA, Das A et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2018;87:944-951.e941.PubMedCrossRef
51.
Zurück zum Zitat Gao DJ, Yang JF, Ma SR et al. Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial. Gastrointest Endosc. 2021;94:91-100.e2.PubMedCrossRef Gao DJ, Yang JF, Ma SR et al. Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial. Gastrointest Endosc. 2021;94:91-100.e2.PubMedCrossRef
52.
Zurück zum Zitat Yang J, Wang J, Zhou H et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial. Endoscopy. 2018;50:751–760.PubMedCrossRef Yang J, Wang J, Zhou H et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial. Endoscopy. 2018;50:751–760.PubMedCrossRef
53.
Zurück zum Zitat Lee YN, Jeong S, Choi HJ et al. The safety of newly developed automatic temperature-controlled endobiliary radiofrequency ablation system for malignant biliary strictures: a prospective multicenter study. J Gastroenterol Hepatol. 2019;34:1454–1459.PubMed Lee YN, Jeong S, Choi HJ et al. The safety of newly developed automatic temperature-controlled endobiliary radiofrequency ablation system for malignant biliary strictures: a prospective multicenter study. J Gastroenterol Hepatol. 2019;34:1454–1459.PubMed
54.
Zurück zum Zitat Kim EJ, Cho JH, Kim YJ et al. Intraductal temperature-controlled radiofrequency ablation in malignant hilar obstruction: a preliminary study in animals and initial human experience. Endosc Int Open. 2019;7:E1293–E1300.PubMedPubMedCentralCrossRef Kim EJ, Cho JH, Kim YJ et al. Intraductal temperature-controlled radiofrequency ablation in malignant hilar obstruction: a preliminary study in animals and initial human experience. Endosc Int Open. 2019;7:E1293–E1300.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Laleman W, van der Merwe S, Verbeke L et al. A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study. Endoscopy. 2017;49:977–982.PubMedCrossRef Laleman W, van der Merwe S, Verbeke L et al. A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study. Endoscopy. 2017;49:977–982.PubMedCrossRef
56.
Zurück zum Zitat Laquière A, Boustière C, Leblanc S, Penaranda G, Désilets E, Prat F. Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma. Surg Endosc. 2016;30:1242–1248.PubMedCrossRef Laquière A, Boustière C, Leblanc S, Penaranda G, Désilets E, Prat F. Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma. Surg Endosc. 2016;30:1242–1248.PubMedCrossRef
57.
Zurück zum Zitat Kallis Y, Phillips N, Steel A et al. Analysis of endoscopic radiofrequency ablation of biliary malignant strictures in pancreatic cancer suggests potential survival benefit. Dig Dis Sci. 2015;60:3449–3455.PubMedCrossRef Kallis Y, Phillips N, Steel A et al. Analysis of endoscopic radiofrequency ablation of biliary malignant strictures in pancreatic cancer suggests potential survival benefit. Dig Dis Sci. 2015;60:3449–3455.PubMedCrossRef
58.
Zurück zum Zitat Sharaiha RZ, Sethi A, Weaver KR et al. Impact of radiofrequency ablation on malignant biliary strictures: results of a collaborative registry. Dig Dis Sci. 2015;60:2164–2169.PubMedCrossRef Sharaiha RZ, Sethi A, Weaver KR et al. Impact of radiofrequency ablation on malignant biliary strictures: results of a collaborative registry. Dig Dis Sci. 2015;60:2164–2169.PubMedCrossRef
59.
Zurück zum Zitat Dolak W, Schreiber F, Schwaighofer H et al. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc. 2014;28:854–860.PubMedCrossRef Dolak W, Schreiber F, Schwaighofer H et al. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc. 2014;28:854–860.PubMedCrossRef
60.
Zurück zum Zitat Sharaiha RZ, Natov N, Glockenberg KS, Widmer J, Gaidhane M, Kahaleh M. Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit? Dig Dis Sci. 2014;59:3099–3102.PubMedCrossRef Sharaiha RZ, Natov N, Glockenberg KS, Widmer J, Gaidhane M, Kahaleh M. Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit? Dig Dis Sci. 2014;59:3099–3102.PubMedCrossRef
61.
Zurück zum Zitat Tal AO, Vermehren J, Friedrich-Rust M, et al. Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction. World J Gastrointest Endosc. 2014;6:13-19.PubMedPubMedCentralCrossRef Tal AO, Vermehren J, Friedrich-Rust M, et al. Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction. World J Gastrointest Endosc. 2014;6:13-19.PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Figueroa-Barojas P, Bakhru MR, Habib NA, et al. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol. 2013;2013:910897.PubMedPubMedCentralCrossRef Figueroa-Barojas P, Bakhru MR, Habib NA, et al. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol. 2013;2013:910897.PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Alis H, Sengoz C, Gonenc M, Kalayci MU, Kocatas A. Endobiliary radiofrequency ablation for malignant biliary obstruction. Hepatobiliary Pancreat Dis Int. 2013;12:423–427.PubMedCrossRef Alis H, Sengoz C, Gonenc M, Kalayci MU, Kocatas A. Endobiliary radiofrequency ablation for malignant biliary obstruction. Hepatobiliary Pancreat Dis Int. 2013;12:423–427.PubMedCrossRef
64.
Zurück zum Zitat Steel AW, Postgate AJ, Khorsandi S et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 2011;73:149–153.PubMedCrossRef Steel AW, Postgate AJ, Khorsandi S et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 2011;73:149–153.PubMedCrossRef
65.
Zurück zum Zitat Song TJ, Seo DW, Lakhtakia S et al. Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc. 2016;83:440–443.PubMedCrossRef Song TJ, Seo DW, Lakhtakia S et al. Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc. 2016;83:440–443.PubMedCrossRef
66.
Zurück zum Zitat Scopelliti F, Pea A, Conigliaro R et al. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer. Surg Endosc. 2018;32:4022–4028.PubMedCrossRef Scopelliti F, Pea A, Conigliaro R et al. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer. Surg Endosc. 2018;32:4022–4028.PubMedCrossRef
67.
Zurück zum Zitat Crinò SF, D’Onofrio M, Bernardoni L et al. EUS-guided radiofrequency ablation (EUS-RFA) of solid pancreatic neoplasm using an 18-gauge needle electrode: feasibility, safety, and technical success. J Gastrointestin Liver Dis. 2018;27:67–72.PubMedCrossRef Crinò SF, D’Onofrio M, Bernardoni L et al. EUS-guided radiofrequency ablation (EUS-RFA) of solid pancreatic neoplasm using an 18-gauge needle electrode: feasibility, safety, and technical success. J Gastrointestin Liver Dis. 2018;27:67–72.PubMedCrossRef
68.
Zurück zum Zitat Arcidiacono PG, Carrara S, Reni M et al. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc. 2012;76:1142–1151.PubMedCrossRef Arcidiacono PG, Carrara S, Reni M et al. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc. 2012;76:1142–1151.PubMedCrossRef
69.
Zurück zum Zitat Squadroni M, Tondulli L, Gatta G, Mosconi S, Beretta G, Labianca R. Cholangiocarcinoma. Crit Rev Oncol Hematol. 2017;116:11–31.PubMedCrossRef Squadroni M, Tondulli L, Gatta G, Mosconi S, Beretta G, Labianca R. Cholangiocarcinoma. Crit Rev Oncol Hematol. 2017;116:11–31.PubMedCrossRef
70.
Zurück zum Zitat Chen Y, Wang XL, Yan ZP et al. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol. 2004;10:3506–3510.PubMedPubMedCentralCrossRef Chen Y, Wang XL, Yan ZP et al. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol. 2004;10:3506–3510.PubMedPubMedCentralCrossRef
71.
Zurück zum Zitat Deufel CL, Furutani KM, Dahl RA et al. Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheter. Brachytherapy. 2018;17:718–725.PubMedCrossRef Deufel CL, Furutani KM, Dahl RA et al. Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheter. Brachytherapy. 2018;17:718–725.PubMedCrossRef
72.
Zurück zum Zitat Mukewar S, Gupta A, Baron TH et al. Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma. Endoscopy. 2015;47:878–883.PubMedCrossRef Mukewar S, Gupta A, Baron TH et al. Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma. Endoscopy. 2015;47:878–883.PubMedCrossRef
73.
Zurück zum Zitat Bhutani MS, Cazacu IM, Luzuriaga Chavez AA et al. Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience. VideoGIE. 2019;4:223–225.PubMedPubMedCentralCrossRef Bhutani MS, Cazacu IM, Luzuriaga Chavez AA et al. Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience. VideoGIE. 2019;4:223–225.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Jin Z, Du Y, Li Z, Jiang Y, Chen J, Liu Y. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy. 2008;40:314–320.PubMedCrossRef Jin Z, Du Y, Li Z, Jiang Y, Chen J, Liu Y. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy. 2008;40:314–320.PubMedCrossRef
76.
Zurück zum Zitat Kim SH, Shin EJ. Endoscopic ultrasound–guided fiducial placement for stereotactic body radiation therapy in pancreatic malignancy. Clin Endosc. 2021;54:314–323.PubMedPubMedCentralCrossRef Kim SH, Shin EJ. Endoscopic ultrasound–guided fiducial placement for stereotactic body radiation therapy in pancreatic malignancy. Clin Endosc. 2021;54:314–323.PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Patel JB, Revanur V, Forcione DG, Bechtold ML, Puli SR. Endoscopic ultrasound-guided fiducial marker placement in pancreatic cancer: A systematic review and meta-analysis. World J Gastrointest Endosc. 2020;12:231–240.PubMedPubMedCentralCrossRef Patel JB, Revanur V, Forcione DG, Bechtold ML, Puli SR. Endoscopic ultrasound-guided fiducial marker placement in pancreatic cancer: A systematic review and meta-analysis. World J Gastrointest Endosc. 2020;12:231–240.PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Caraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma. Cancer. 1996;78:639–653.PubMedCrossRef Caraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma. Cancer. 1996;78:639–653.PubMedCrossRef
79.
Zurück zum Zitat Lu F, Dong J, Tang Y, et al. .Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and meta-analysis. Support Care Cancer. 2018;26:353–359. Lu F, Dong J, Tang Y, et al. .Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and meta-analysis. Support Care Cancer. 2018;26:353–359.
80.
Zurück zum Zitat Kaufman M, Singh G, Das S et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44:127–134.PubMedCrossRef Kaufman M, Singh G, Das S et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44:127–134.PubMedCrossRef
81.
Zurück zum Zitat Puli SR, Reddy JB, Bechtold ML, Antillon MR, Brugge WR. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci. 2009;54:2330–2337.PubMedCrossRef Puli SR, Reddy JB, Bechtold ML, Antillon MR, Brugge WR. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci. 2009;54:2330–2337.PubMedCrossRef
82.
Zurück zum Zitat Koulouris AI, Alexandre L, Hart AR, Clark A. Endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) technique and analgesic efficacy in patients with pancreatic cancer: A systematic review and meta-analysis. Pancreatology. 2021;21:434–442.PubMedCrossRef Koulouris AI, Alexandre L, Hart AR, Clark A. Endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) technique and analgesic efficacy in patients with pancreatic cancer: A systematic review and meta-analysis. Pancreatology. 2021;21:434–442.PubMedCrossRef
83.
Zurück zum Zitat Han CQ, Tang XL, Zhang Q, Nie C, Liu J, Ding Z. Predictors of pain response after endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain caused by pancreatic malignancy. World J Gastroenterol. 2021;27:69–79.PubMedPubMedCentralCrossRef Han CQ, Tang XL, Zhang Q, Nie C, Liu J, Ding Z. Predictors of pain response after endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain caused by pancreatic malignancy. World J Gastroenterol. 2021;27:69–79.PubMedPubMedCentralCrossRef
84.
Zurück zum Zitat Iwata K, Yasuda I, Enya M et al. Predictive factors for pain relief after endoscopic ultrasound-guided celiac plexus neurolysis. Dig Endosc. 2011;23:140–145.PubMedCrossRef Iwata K, Yasuda I, Enya M et al. Predictive factors for pain relief after endoscopic ultrasound-guided celiac plexus neurolysis. Dig Endosc. 2011;23:140–145.PubMedCrossRef
85.
Zurück zum Zitat Fujii-Lau LL, Bamlet WR, Eldrige JS et al. Impact of celiac neurolysis on survival in patients with pancreatic cancer. Gastrointest Endosc. 2015;82:46-56.e42.PubMedPubMedCentralCrossRef Fujii-Lau LL, Bamlet WR, Eldrige JS et al. Impact of celiac neurolysis on survival in patients with pancreatic cancer. Gastrointest Endosc. 2015;82:46-56.e42.PubMedPubMedCentralCrossRef
86.
Zurück zum Zitat Sahai AV. EUS-guided celiac ganglia neurolysis versus celiac plexus neurolysis: dying to know which is better. Gastrointest Endosc. 2017;86:664–665.PubMedCrossRef Sahai AV. EUS-guided celiac ganglia neurolysis versus celiac plexus neurolysis: dying to know which is better. Gastrointest Endosc. 2017;86:664–665.PubMedCrossRef
87.
Zurück zum Zitat Levy MJ, Gleeson FC, Topazian MD et al. Combined celiac ganglia and plexus neurolysis shortens survival, without benefit, vs plexus neurolysis alone. Clin Gastroenterol Hepatol. 2019;17:728-738.e9.PubMedCrossRef Levy MJ, Gleeson FC, Topazian MD et al. Combined celiac ganglia and plexus neurolysis shortens survival, without benefit, vs plexus neurolysis alone. Clin Gastroenterol Hepatol. 2019;17:728-738.e9.PubMedCrossRef
88.
Zurück zum Zitat Bang JY, Sutton B, Hawes RH, Varadarajulu S. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos). Gastrointest Endosc. 2019;89:58-66.e3.PubMedCrossRef Bang JY, Sutton B, Hawes RH, Varadarajulu S. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos). Gastrointest Endosc. 2019;89:58-66.e3.PubMedCrossRef
Metadaten
Titel
Endoscopic Management of Pancreatobiliary Malignancies
verfasst von
Dong Wook Lee
Eun Young Kim
Publikationsdatum
16.02.2022
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07394-y

Weitere Artikel der Ausgabe 5/2022

Digestive Diseases and Sciences 5/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.